Analyst firms · Bernstein · REGN
Bernstein REGN price target and rating history
Regeneron Pharmaceuticals Inc. (REGN) · Health Care
Bernstein rates Regeneron Pharmaceuticals Inc. (REGN) Outperform with a $1,125 price target, as of its latest action on Mar 12, 2024. It has published 3 rating actions on REGN since December 2021, including 1 upgrade and 1 downgrade. Across 10 firms with a REGN price target in the last 12 months, the median target is $782.50.
- Current rating
- Outperform
- Price target
- $1,125
- Median target, all firms
- $782.50
- Actions on REGN
- 3
Bernstein price target on REGN
Every Bernstein rating on REGN
- Mar 12, 2024
- Jan 3, 2022
- Dec 15, 2021
How other firms rate REGN
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Argus Research | Buy | $850 | Oct 1, 2026 |
| Citigroup | Neutral | $700 | May 18, 2026 |
| Leerink Partners | Market Perform | $641 | May 18, 2026 |
| Piper Sandler | Overweight | $875 | Mar 31, 2026 |
| Barclays | Overweight | $923 | Mar 6, 2026 |
| BofA Securities | Buy | $860 | Jan 7, 2026 |
| Morgan Stanley | Equal-Weight | $767 | Dec 3, 2025 |
| Truist Securities | Buy | $798 | Nov 24, 2025 |
| HSBC | Buy | $255 | Nov 24, 2025 |
| Scotiabank | Sector Perform | $650 | Nov 13, 2025 |
Questions about Bernstein and REGN
- What is Bernstein's price target for REGN?
- Bernstein's latest stated price target for Regeneron Pharmaceuticals Inc. (REGN) is $1,125, from its action on Mar 12, 2024.
- What is Bernstein's rating on REGN?
- Bernstein rates REGN Outperform, a bullish rating, as of Mar 12, 2024.
- When did Bernstein last change its view on REGN?
- On Mar 12, 2024, Bernstein starts coverage at Outperform, price target $1,125.
- How does Bernstein's REGN target compare with other analysts?
- Across 10 firms with a REGN price target in the last 12 months, the median target is $782.50.
More REGN rating histories
- Citigroup3
- Leerink Partners9
- BofA Securities3
- Morgan Stanley7
- Truist Securities3
- Raymond James3
- Oppenheimer3
- Jefferies3
- The Benchmark Company3
- H.C. Wainwright5
All Bernstein ratingsREGN news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.